Date of dispatch of this notice: 07/08/2019
External Reference: 2019-288010
TED Reference: 2019/S 154-379584
Contract award notice
Information
Published
Contract award notice
Cached Version
Contract award notice
Results of the procurement procedure
Directive 2014/24/EU
Section I: Contracting authority
I.1)
Name and addresses
St James's Hospital
N/A
James Street
Dublin
Dublin 8
IE
Contact person:
David Gunning
Telephone:
+353 14284707
E-mail:
DGunning@STJAMES.IE
NUTS code:
IE -
IRELAND
Main address:
http://www.stjames.ie
Address of the buyer profile:
https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/395
I.4)
Type of the contracting authority
Body governed by public law
I.5)
Main activity
Health
Section II: Object
II.1)
Scope of the procurement
II.1.1)
Title
Provision of Fluorescent in situ Hybridisation (FISH) Services
II.1.2)
Main CPV code
38000000
-
Laboratory, optical and precision equipments (excl. glasses)
II.1.3)
Type of contract
Supplies
II.1.4)
Short description
The Fluorescent in-situ hybridisation (FISH) laboratory in the Histopathology Department at St. James’s Hospital has provided a hospital and national service since the 2010. The service is staffed by two medical scientists. Currently the service offers the following assays for diagnostics and predictive testing:
• Her2 gene amplification found in Breast/Gastric/Colorectal Cancer
• Gene rearrangement /translocations found in Lymphomas
• Alk and ROS1 gene rearrangement found in NSCLC
The Fluorescent in-situ hybridisation (FISH) technique is performed as a semi-automated assay, on formalin fixed paraffin embedded material.
Future Development
Possible introduction of additional esoteric FISH testing for Lymphoma nationally
• DUSP22, TP63 rearrangements
• 11q aberration.
Possible development of Myeloma FISH service.
• Her2 gene amplification found in Breast/Gastric/Colorectal Cancer
• Gene rearrangement /translocations found in Lymphomas
• Alk and ROS1 gene rearrangement found in NSCLC
The Fluorescent in-situ hybridisation (FISH) technique is performed as a semi-automated assay, on formalin fixed paraffin embedded material.
Future Development
Possible introduction of additional esoteric FISH testing for Lymphoma nationally
• DUSP22, TP63 rearrangements
• 11q aberration.
Possible development of Myeloma FISH service.
II.1.6)
Information about lots
This contract is divided into lots:
no
II.1.7)
Total value of the procurement
Value excluding VAT:
200000.00
EUR
II.2)
Description
II.2.2)
Additional CPV code(s)
33000000
-
Medical equipments, pharmaceuticals and personal care products
33100000
-
Medical equipments
33124110
-
Diagnostic systems
33141625
-
Diagnostic kits
33694000
-
Diagnostic agents
38434540
-
Biomedical equipment
51430000
-
Installation services of laboratory equipment
71900000
-
Laboratory services
85121200
-
Medical specialist services
85145000
-
Services provided by medical laboratories
II.2.3)
Place of performance
NUTS code:
IE -
IRELAND
Main site or place of performance:
St James's Hospital
II.2.4)
Description of the procurement
The Fluorescent in-situ hybridisation (FISH) laboratory in the Histopathology Department at St. James’s Hospital has provided a hospital and national service since the 2010. The service is staffed by two medical scientists. Currently the service offers the following assays for diagnostics and predictive testing:
• Her2 gene amplification found in Breast/Gastric/Colorectal Cancer
• Gene rearrangement /translocations found in Lymphomas
• Alk and ROS1 gene rearrangement found in NSCLC
The Fluorescent in-situ hybridisation (FISH) technique is performed as a semi-automated assay, on formalin fixed paraffin embedded material.
Future Development
Possible introduction of additional esoteric FISH testing for Lymphoma nationally
• DUSP22, TP63 rearrangements
• 11q aberration.
Possible development of Myeloma FISH service.
• Her2 gene amplification found in Breast/Gastric/Colorectal Cancer
• Gene rearrangement /translocations found in Lymphomas
• Alk and ROS1 gene rearrangement found in NSCLC
The Fluorescent in-situ hybridisation (FISH) technique is performed as a semi-automated assay, on formalin fixed paraffin embedded material.
Future Development
Possible introduction of additional esoteric FISH testing for Lymphoma nationally
• DUSP22, TP63 rearrangements
• 11q aberration.
Possible development of Myeloma FISH service.
II.2.5)
Award criteria
Criteria below
Quality criterion
-
Name:
quality
/
Weighting:
60
Cost criterion
-
Name:
price
/
Weighting:
40
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
Section IV: Procedure
IV.1)
Description
IV.1.1)
Type of procedure
Competitive dialogue
IV.1.8)
Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement
: no
IV.2)
Administrative information
IV.2.1)
Previous publication concerning this procedure
Notice number in the OJ S: 2017/S 230-479093
Section V: Award of contract
Contract No: 1
Title: Provision of Fluorescent in situ Hybridisation (FISH) Services
V.2)
Award of contract
V.2.1)
Date of conclusion of the contract
07/08/2019
V.2.2)
Information about tenders
Number of tenders received:
3
Number of tenders received by electronic means:
3
The contract has been awarded to a group of economic operators
:
noV.2.3)
Name and address of the contractor
Leica Microsystems (UK) Ltd
476611
Larch House, Woodlands Business Park,
Milton Keynes, MK14 6FG
Breckland, Linford W
UK
Telephone:
+44 01908246246
Fax:
+44 01908577640
NUTS code:
IE -
IRELAND
Internet address:
http://www.leica-microsystems.com
The contractor is an SME : no
V.2.4)
Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
600000.00
EUR
Total value of the contract/lot:
200000.00
EUR
Section VI: Complementary information
VI.4)
Procedures for review
VI.4.1)
Review body
Hig Court
Dublin
Dublin
IE